![]() |
市場調查報告書
商品編碼
1345321
全球癌症治療市場 - 市場規模、佔有率、成長分析:按用途(血癌、肺癌)、治療方法(化療、標靶治療) - 行業預測(2023-2030)Global Cancer Therapeutics Market Size, Share, Growth Analysis, By Application (Blood cancer, lung cancer), By Therapy(Chemotherapy, targeted therapy) - Industry Forecast 2023-2030 |
2021年全球癌症治療藥物市場規模為1665億美元。該市場預測將從2022年的1816.5億美元成長到2030年的3646.2億美元。
全球癌症藥物市場是醫療保健行業中一個充滿活力且快速發展的部分。該市場包括針對不同類型癌症的多種治療方法,包括化療、免疫治療、標靶治療和放射治療。隨著全球癌症罹患率的增加,該市場的特點是持續的研發努力、創新的新藥發現以及精準醫療的進步。這個市場的主要參與企業包括製藥公司、生物技術公司和研究機構,他們都在努力尋求在與癌症的持續鬥爭中提供更好的治療選擇並改善患者的治療結果。
全球癌症罹患率上升是癌症治療市場成長的關鍵促進因素。高齡化、生活方式的改變和環境暴露等要素導致各種癌症的患病率不斷增加,從而對有效治療方案的需求不斷成長。
基因組學、蛋白質組學和分子診斷學的技術進步正在提高我們對癌症生物學的理解。這些知識促進了標靶治療和個人化醫療的發展,從而改善了治療結果並減少了副作用。
許多癌症治療,尤其標靶治療和免疫治療,都很昂貴。高昂的治療費用限制了低收入地區患者的治療機會,並增加了個人和醫療保健系統的經濟負擔。
儘管癌症治療在減少副作用方面取得了長足進步,但某些治療方法(例如化療)仍然會引起副作用和毒性。潛在的嚴重副作用可能會影響治療期間患者的依從性和生活品質。
隨著用於癌症治療的幾種生物製劑的專利到期,生物學名藥的開發和批准正在增加。生物學名藥為昂貴的癌症生物製劑提供了一種經濟高效的替代品,並改善了患者獲得治療的機會。
該報告考察了全球癌症治療市場,並提供了市場概述,包括按用途、治療、地區和參與市場的公司概況分類的趨勢。
Global Cancer Therapeutics Market size was valued at USD 166.5 Billion in 2021 and is poised to grow from USD 181.65 Billion in 2022 to USD 364.62 Billion by 2030,
The Global Cancer Therapeutics Market is a dynamic and rapidly evolving sector within the healthcare industry. It encompasses a wide range of treatments, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, aimed at combating various types of cancer. With increasing cancer incidence worldwide, the market is characterized by constant research and development efforts, innovative drug discoveries, and advancements in precision medicine. Key players in this market include pharmaceutical companies, biotechnology firms, and research institutions, all striving to provide better therapeutic options and improve patient outcomes in the ongoing battle against cancer.
Top-down and bottom-up approaches were used to estimate and validate the size of Cancer Therapeutics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cancer Therapeutics Market Segmental Analysis Report
The global cancer therapeutics market is segmented on the basis of application, therapy, and region. By application, the market is segmented into blood cancer, lung cancer, and other types of cancer. By therapy, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and other treatment modalities. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Cancer Therapeutics Market Dynamics
Driver:
Rising Cancer Prevalence
The increasing incidence of cancer worldwide is a significant driver for the growth of the cancer therapeutics market. Factors such as an aging population, lifestyle changes, and environmental exposures contribute to the higher prevalence of various cancer types, creating a growing demand for effective treatment options.
Advancements in Medical Technology
Technological advancements in genomics, proteomics, and molecular diagnostics have enabled better understanding of cancer biology. This knowledge has led to the development of targeted therapies and personalised medicine, improving treatment outcomes and reducing side effects.
Restraint:
High Cost of Cancer Treatments
Many cancer therapies, especially targeted therapies and immunotherapies, are expensive. The high cost of treatment can limit access for patients in low-income regions and contribute to financial burden, both for individuals and healthcare systems.
Side Effects and Toxicity
While cancer therapies have made significant progress in reducing side effects, some treatments, such as chemotherapy, can still cause adverse reactions and toxicity. The potential for severe side effects may impact patient compliance and quality of life during treatment.
Global Cancer Therapeutics Key Market Trends
Development of Biosimilars: With several biologics used in cancer treatment coming off-patent, there has been an increase in the development and approval of biosimilars. Biosimilars offer cost-effective alternatives to expensive cancer biologics, increasing patient access to treatment.
Personalized Cancer Vaccines: The development of personalised cancer vaccines is a promising area of research. These vaccines are tailored to individual patients based on their tumour's genetic profile, potentially offering a more targeted and effective treatment approach.